Shares of Solid Biosciences rose after the life-sciences company provided updates on multiple continuing trials, including dosing initiation and a fast-track designation in the U.S. for one drug. The ...

Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.

Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company” or "Solid”), a life sciences company developing precision genetic ...

Milestone Pharmaceuticals ( ($MIST) ) has issued an announcement. On January 6, 2026, Milestone Pharmaceuticals announced that the European ...

Anja Wilson was a kind and thoughtful young woman who had finished her A-levels in Halifax and was about to study Biology at ...

In recent years, the Air Jordan 17 has become one of the most coveted of Jordan's post-Chicago Bulls sneakers. This is due in ...

European decision on approval is expected by Q1 2027If approved, etripamil nasal spray is expected to offer patients a safe and effective ...

The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...

Caplacizumab is a von Willebrand factor (vWF)-directed antibody fragment designed to inhibit the interaction between vWF and platelets.

SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations - - Dosing of the first participant in the Phase 1b FALCON trial has been completed, with initial data expected ...

Purchasing life insurance for a child can provide a safety net if the worst should happen, but it can also protect them well into adulthood. There are different plans that parents, grandparents or ...

The royal family will gather today to mourn Katharine, Duchess of Kent, who passed away in early September at age 92. Prince Edward, the Duke of Kent and Katharine have three children and ten ...